🔎 Trials Near Me

Hem › Typ 1-diabetes › Washington

Kliniska studier för Typ 1-diabetes i Washington

20 studier för Typ 1-diabetes söker deltagare vid platser i Washington.

Städer i Washington

Officiell studietext (engelska)

Type 1 Diabetes Extension Study

  • Benaroya Research Institute, Seattle
RekryterarObservationsstudie
Ålder 8 till 35 · Alla kön · Uppdaterad 18 sep. 2026 · NCT02734277

METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)

  • University of Washington Medicine Diabetes Institute (UWMDI), Seattle
RekryterarFas 2
Ålder 18 till 69 · Alla kön · Uppdaterad 15 sep. 2026 · NCT07699380

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

  • Benaroya Research Institute at Virginia Mason- Site Number : 8400038, Seattle
  • MultiCare Mary Bridge Children's Health Center- Site Number : 8400037, Tacoma
RekryterarFas 3
Ålder 1 till 25 · Alla kön · Uppdaterad 14 sep. 2026 · NCT07088068

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

  • Benaroya Research Institute, Seattle
  • University of Washington Diabetes Institute, Seattle
RekryterarFas 1/2
Ålder 12 till 35 · Alla kön · Uppdaterad 11 sep. 2026 · NCT06783309

Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG

  • Benaroya Research Institute, Seattle
RekryterarFas 2
Ålder 4 till 34 · Alla kön · Uppdaterad 9 sep. 2026 · NCT07216391

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

  • Benaroya Research Institute, Seattle
RekryterarFas 2
Ålder 8 till 45 · Alla kön · Uppdaterad 8 sep. 2026 · NCT07142252

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

  • Seattle Children's Hospital, Seattle
RekryterarFas 1/2
Ålder 9 till 20 · Alla kön · Uppdaterad 2 sep. 2026 · NCT07061574

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

  • Benaroya Research Institute at Virginia Mason, Seattle
  • Mary Bridge Children's Outpatient Center - Tacoma, Tacoma
RekryterarFas 2
Ålder 5 till 40 · Alla kön · Uppdaterad 24 aug. 2026 · NCT07187531

Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery

  • University of Washington, Seattle
Rekryterar
Ålder 18 till 65 · Alla kön · Uppdaterad 16 juli 2026 · NCT06880835

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

  • University of Washington, Seattle
  • Providence Sacred Heart Medical Center, Spokane
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 2 juni 2026 · NCT05822609

Kidney Precision Medicine Project

  • University of Washington, Seattle
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 14 apr. 2026 · NCT04334707

Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM

  • Rainier Clinical Reseach Center, Renton
Rekryterar
Ålder 18 till 65 · Alla kön · Uppdaterad 9 apr. 2026 · NCT07296276

Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus

  • Rainier Clinical Research Center, Renton
RekryterarFas 2
Ålder 18 till 50 · Alla kön · Uppdaterad 6 apr. 2026 · NCT06964087

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

  • University of Washington, Seattle
  • Providence Sacred Heart Medical Center, Spokane
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 24 mars 2026 · NCT06217302

Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes

  • University of Washington Medicine Diabetes Institute (UWMDI), Seattle
RekryterarFas 3
Ålder 18 till 49 · Alla kön · Uppdaterad 4 mars 2026 · NCT05819138

EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)

  • Benaroya Research Institute, Seattle
RekryterarObservationsstudie
Upp till ålder 70 · Alla kön · Uppdaterad 19 dec. 2025 · NCT03369821

InvesT1D: Promoting Adolescent Investment in Diabetes Care

  • Seattle Children's, Seattle
Rekryterar
Ålder 12 och äldre · Alla kön · Uppdaterad 16 dec. 2025 · NCT06384911

TrialNet Pathway to Prevention of T1D

  • Benaroya Research Institute, Seattle
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 2 till 45 · Alla kön · Uppdaterad 1 juli 2025 · NCT00097292

MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes

  • Seattle Children's Hospital, Seattle
RekryterarFas 1
Ålder 12 till 25 · Alla kön · Uppdaterad 13 juni 2025 · NCT05065372

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.